Hilde Hermansen Steineger
Oprichter bij NorthSea Therapeutics BV
Oorsprong van het eerstegraads netwerk van Hilde Hermansen Steineger
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
University of Oslo
47
| College/University | Other Consumer Services | 47 |
31
| Extinct | Pharmaceuticals: Major | 31 |
23
| Subsidiary | Pharmaceuticals: Major | 23 |
| Extinct | Pharmaceuticals: Major | 22 | |
Pronova BioPharma ASA
 Pronova BioPharma ASA Pharmaceuticals: MajorHealth Technology Pronova BioPharma ASA engages in the research, development, and manufacture of lipid therapies derived from nature. Its products are used for providing enteral and parenteral nutrition solutions, and dietary supplements; and treating metabolic and cardiovascular disorders. The company was founded in 1838 and is headquartered in Lysaker, Norway.
22
| Extinct | Pharmaceuticals: Major | 22 |
NorthSea Therapeutics BV
 NorthSea Therapeutics BV BiotechnologyHealth Technology NorthSea Therapeutics BV operates as a biotechnology company. It develops oral, structurally engineered fatty acid therapeutics. The company was founded by Hilde H. Steineger and David A. Fraser and is headquartered in Naarden, the Netherlands.
13
| Holding Company | Biotechnology | 13 |
| Public Company | Biotechnology | 9 | |
Cortendo AB
 Cortendo AB Miscellaneous Commercial ServicesCommercial Services Cortendo AB engages in the provision of biopharmaceutical business. Its activities include development and distribution of orphan drugs for metabolic and endocrine diseases as well as diabetes. Its products include cortisol inhibition and normocort. The company was founded on October 6, 1996 and is headquartered in Trevose, PA.
8
| Subsidiary | Miscellaneous Commercial Services | 8 |
| Public Company | Medical Specialties | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Hilde Hermansen Steineger via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BI Norwegian Business School | College/University | Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Undergraduate Degree Undergraduate Degree | |
| VISTIN PHARMA ASA | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chairman Director/Board Member Chief Operating Officer | |
| University of Lund | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| PHOTOCURE ASA | Medical Specialties | Director of Finance/CFO Director/Board Member Chairman Corporate Officer/Principal | |
| Norwegian School of Economics & Business Administration | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Norwegian University of Science & Technology | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| NEL ASA | Industrial Machinery | Corporate Officer/Principal Chief Operating Officer Chairman | |
| MELINTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chairman | |
| XERIS BIOPHARMA HOLDINGS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor Founder Private Equity Investor | |
Oncoinvent AS
 Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Chief Executive Officer Founder Director/Board Member | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| PROTECTOR FORSIKRING ASA | Property/Casualty Insurance | Director/Board Member Director/Board Member | |
Zelluna Immunotherapy AS
 Zelluna Immunotherapy AS BiotechnologyHealth Technology Zelluna Immunotherapy AS engages in research and development on biotechnology. The company is headquartered in Oslo, Norway. | Biotechnology | Director/Board Member Founder | |
Schering-Plough Research Institute
 Schering-Plough Research Institute Medical SpecialtiesHealth Technology Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
VirMedica, Inc.
 VirMedica, Inc. Packaged SoftwareTechnology Services VirMedica, Inc. provides technology solutions which designed to optimize the commercialization of specialty pharmaceutical products. It is an innovative holding company bringing together complimentary businesses for the specific purpose of redefining the market access landscape for specialty products. The company’s technology solution offers an end-to-end transformational platform to optimize specialty product commercialization and management. The company was founded by Mark K. Barnes in 2013 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member | |
| AXACTOR ASA | Miscellaneous Commercial Services | Chairman Compliance Officer | |
| CORCEPT THERAPEUTICS INCORPORATED | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SUCAMPO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Xention Pharma Ltd.
 Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Xention Ltd.
 Xention Ltd. Pharmaceuticals: MajorHealth Technology Part of Xention Pharma Ltd., Xention Ltd. is a British company that develops and researches drugs. The company is based in Newmarket, UK. Xention was founded in 2002. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment Inc (Sofinnova Investment) is a venture capital firm founded in 1976 by Jacques F. vallle & Joel F. Martin. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor Private Equity Investor | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Doctorate Degree | |
| CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Biotechnology | Director/Board Member Director/Board Member | |
Reaction Biology Corp.
 Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Miscellaneous Commercial Services | Chief Executive Officer Director of Finance/CFO | |
| ELLIPTIC LABORATORIES ASA | Semiconductors | Chief Tech/Sci/R&D Officer Founder | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
| Imperial College London | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chairman Founder | |
Weifa AS
 Weifa AS Pharmaceuticals: MajorHealth Technology Weifa AS operates as a pharmaceutical company. The firm supplies non-prescription, over the counter medicines, and lifestyle products. It offers medicines for pain, fever, muscle and joint, colds, wound, as well as vitamins, minerals, and prescription products. The company was founded by Olaf Weider in 1940 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SAVARA INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
Media Network Services AS
 Media Network Services AS Packaged SoftwareTechnology Services Media Network Services AS provides network and infrastructure services for video conferences. It offers its services to video conferencing services providers and internet service providers. The firm's VideoRoaming provides video conferencing users with quality and reach regardless of when and where they video call. Its MCU1.com provides video conferencing users with easy-to-use Virtual Meeting Rooms (VMR) on the next generation Multipoint Control Unit (MCU). The company was founded by Tarik Cicic in 2007 and is headquartered in Oslo, Norway. | Packaged Software | Corporate Officer/Principal Founder |
Statistieken
Internationaal
| Verenigde Staten | 24 |
| Noorwegen | 15 |
| Verenigd Koninkrijk | 6 |
| Zweden | 4 |
| Nederland | 4 |
Sectoraal
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 4 |
| Technology Services | 3 |
Operationeel
| Director/Board Member | 604 |
| Corporate Officer/Principal | 183 |
| Chairman | 138 |
| Independent Dir/Board Member | 129 |
| Chief Executive Officer | 79 |
Sterkste connecties
| Insiders | |
|---|---|
| Martin Nes | 79 |
| Garheng Kong | 61 |
| Somu Subramaniam | 48 |
| John Johnson | 40 |
| Per Anders Göte Samuelsson | 36 |
| Hugo Slootweg | 34 |
| Jan Hendrik Egberts | 33 |
| David Gill | 32 |
| Richard Kollender | 30 |
| Robert Spiegel | 30 |
| Anders Paul Wiklund | 29 |
| Karin Judith Meyer-Rosberg | 26 |
| Jean Bizzari | 24 |
| Edward Karol Sikora | 23 |
| Ludvik Sandnes | 22 |
- Beurs
- Insiders
- Hilde Hermansen Steineger
- Bedrijfsconnecties